文献速递流行病学与生物统计临床试验与 GCP

通过模拟评估贝叶斯最优设计的频率学派操作特征

Frequentist operating characteristics of Bayesian optimal designs via simulation.
PubMed 文献 · Stat Med · 2019-06-19

本文提出一种基于模拟的通用方法,用于在频率学派标准(如把握度)下比较频率学派设计与贝叶斯自适应设计,并计算有效的频率学派 p 值。以等随机化(ER)设计与最优贝叶斯自适应(OBA)设计为例比较把握度,结果显示大患者地平线时两标准一致,小而患者地平线时差异可能显著。

要点

  • 提出基于模拟的通用方法,可在频率学派标准下比较频率学派与贝叶斯自适应设计。
  • OBA 设计的把握度除依赖疗效和样本量外,还依赖患者地平线大小。
  • 大患者地平线时频率学派与贝叶斯标准一致,小患者地平线时差异可能显著。

核心结论

  • 对于大患者地平线,频率学派与贝叶斯标准下的把握度一致,而对于小患者地平线,差异可能显著。
  • 结果量化了把握度与试验内最优患者分配之间的权衡。

研究设计与样本

  • 提出一种基于模拟的通用方法,用于在频率学派标准下比较频率学派设计与贝叶斯自适应设计,并计算有效的频率学派 p 值。
  • 通过比较等随机化(ER)设计与最优贝叶斯自适应(OBA)设计的把握度来展示该方法。
  • 所考虑的贝叶斯设计为动态规划解,优化由患者地平线内成功数定义的特定效用函数,患者地平线包括试验结束后治疗受试验结果影响的患者。

主要发现

  • ER 设计的把握度取决于治疗疗效和样本量,而 OBA 设计的把握度还取决于患者地平线大小。
  • 对于大患者地平线,两种标准(频率学派与贝叶斯)一致;对于小患者地平线,差异可能显著。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Bayesian adaptive designs have become popular because of the possibility of increasing the number of patients treated with more beneficial treatments, while still providing sufficient evidence for treatment efficacy comparisons. It can be essential, for regulatory and other purposes, to conduct frequentist analyses both before and after a Bayesian adaptive trial, and these remain challenging. In this paper, we propose a general simulation-based approach to compare frequentist designs with Bayesian adaptive designs based on frequentist criteria such as power and to compute valid frequentist p-values. We illustrate our approach by comparing the power of an equal randomization (ER) design with that of an optimal Bayesian adaptive (OBA) design. The Bayesian design considered here is the dynamic programming solution of the optimization of a specific utility function defined by the number of successes in a patient horizon, including patients whose treatment will be affected by the trial's results after the end of the trial. While the power of an ER design depends on treatment efficacy and the sample size, the power of the OBA design also depends on the patient horizon size. Our results quantify the trade-off between power and the optimal assignment of patients to treatments within the trial. We show that, for large patient horizons, the two criteria are in agreement, while for small horizons, differences can be substantial. This has implications for precision medicine, where patient horizons are decreasing as a result of increasing stratification of patients into subpopulations defined by molecular markers.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Trippa L, Parmigiani G, et al. Frequentist operating characteristics of Bayesian optimal designs via simulation. Stat Med. 2019. PMID: 31215685. doi:10.1002/sim.8279

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。